about
Harnessing the immune system to improve cancer therapyAdvanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious DiseasesMitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Self-assembling protein nanoparticles in the design of vaccinesNanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyParticulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensTargeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future PerspectivesPoly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccineCytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model.Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.Targeting Treg signaling for the treatment of autoimmune diseasesLipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona FormationPolymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy.Bio-inspired virus-like nanovesicle for effective vaccination.Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.Specific and Efficient Uptake of Surfactant-Free Poly(Lactic Acid) Nanovaccine Vehicles by Mucosal Dendritic Cells in Adult Zebrafish after Bath Immersion.Recruitment of bone marrow CD11b+Gr-1+ cells by polymeric nanoparticles for antigen cross-presentation.Harnessing Nanoparticles for Immunomodulation and VaccinesDendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.Mucosal vaccine delivery: Current state and a pediatric perspectiveCovalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.Biomaterials for enhancing anti-cancer immunity.Multifunctional nanoparticles for cancer immunotherapy.Development of poly(lactide-co-glycolide) nanoparticles functionalized with a mitochondria penetrating peptide.Human immune cell targeting of protein nanoparticles--caveospheres.Recent advances in the use of nanoparticles for allergen-specific immunotherapy.Self-assembling peptide-based building blocks in medical applications.Emerging nanotechnologies for cancer immunotherapyStrategies for designing synthetic immune agonists.Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?The Density Code for the Development of a Vaccine?Recent progress on the development of anisotropic gold nanoparticles: Design strategies and growth mechanism.T cell immunoengineering with advanced biomaterials.Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.Nanoformulations for combination or cascade anticancer therapy.Glyco-gold nanoparticles: synthesis and applications.
P2860
Q26738698-F6FA1CE5-FCB5-478A-A3DC-3EDDDF35E632Q26744748-44654000-4349-47B8-8306-D074584DC934Q26748776-F08D0A69-22C9-419E-B97B-5540394C0046Q26767097-35226617-291C-445A-A80B-5474F519F10DQ26782566-CE2C7B9E-2C10-4C60-9907-4AFD0921A529Q27011190-4B85E5CD-94BD-4027-8037-66A215438886Q28066286-FCC1C34E-6FA0-4003-AF95-189A28A39B29Q30400146-C8891928-32F2-42B8-8E4C-5E44BC300FC6Q33875615-92F3E4E2-E445-4B5D-B808-287C6826DBA8Q36202229-FEBBC14E-CBF7-48B7-A61A-8A4A9BFB7D4BQ36257481-7A96FF66-2E87-45DA-AAC3-779F23B06741Q36372616-C873154A-D046-4906-AED6-840A5CE48027Q36828184-46D8538E-E6B2-4B4C-8C3F-9E86B0BCE5E4Q37167802-EAA6AA0B-0536-47D9-B5D0-AF1BC27CB0BBQ37191649-2A18CA1B-6AC2-4C4B-9165-4582DB83DDCDQ37197146-BBD6AA6E-8E86-47F4-A05C-2EDD603FC8A1Q37577596-FBAF7859-F7B4-4B96-B1B4-0C26B0D70334Q37667212-EA19DE59-09A0-4719-8B68-727CBC0B769CQ37710630-B1B3316F-B62D-4B7B-9148-9241D1178CDEQ37727724-B634AD63-67A2-4D7B-AFDB-ABDAE9ACBE3FQ37834084-D657A6F0-04CE-4E4D-9CD7-05B025D0E450Q38680785-22D24FA8-DEE4-4ACD-8D1C-DAEA60B103E6Q38727453-5A000B40-5243-41CE-BA3B-30286169FD5FQ38737582-7373F6F9-3655-4617-A792-E1B4EED3B087Q38741829-461151A3-DF02-4354-AF99-4DF986255F26Q38744042-63D900B8-1CE8-443D-AF2E-38A48DCBD1C2Q38769737-98AF802B-E795-4674-AE99-04471D974E2EQ38782237-C6DA7C8F-E2ED-4A0B-99D9-AB71F19F6BD4Q38802840-2771A3E7-ABFA-4D52-83B3-588AFB681DDCQ38830346-D833B1A4-0969-4F78-9D19-8A7DA3627966Q38837036-4C0D1AD2-FDDF-45E0-89F6-44ADA31A2FFBQ38841677-C6C1C23F-12A4-44FF-BC11-7FCE18290E6BQ38886698-C99E9051-722A-45C0-96AB-390CCBEC882BQ38912004-093C9C1D-1617-4FEC-BF05-D4C15D7F31BCQ38959835-1C40E83B-1A3B-4359-BEA6-8D8601B106CEQ39091937-04CA3D51-1A35-46D7-9B3B-B749B2C78E73Q39157864-65AE3070-511E-4066-8B1D-F1E531AFAA3EQ39159035-AFEDAD7B-BFC8-4F9E-98E7-2C784D0751DAQ39380111-44B0E6D5-7F93-4CF7-B0B9-238F4410367DQ39419658-50752CA5-5C70-4E61-8E06-ACADBD8A45F1
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Synthetic Nanoparticles for Vaccines and Immunotherapy
@ast
Synthetic Nanoparticles for Vaccines and Immunotherapy
@en
Synthetic Nanoparticles for Vaccines and Immunotherapy
@nl
type
label
Synthetic Nanoparticles for Vaccines and Immunotherapy
@ast
Synthetic Nanoparticles for Vaccines and Immunotherapy
@en
Synthetic Nanoparticles for Vaccines and Immunotherapy
@nl
prefLabel
Synthetic Nanoparticles for Vaccines and Immunotherapy
@ast
Synthetic Nanoparticles for Vaccines and Immunotherapy
@en
Synthetic Nanoparticles for Vaccines and Immunotherapy
@nl
P2093
P2860
P3181
P1433
P1476
Synthetic Nanoparticles for Vaccines and Immunotherapy
@en
P2093
Darrell J Irvine
Kavya Rakhra
Talar Tokatlian
P2860
P304
11109-11146
P3181
P356
10.1021/ACS.CHEMREV.5B00109
P407
P577
2015-07-08T00:00:00Z